Late-onset neuroleptic malignant syndrome in a patient using olanzapine.
Kunz
Maurício
M
Gomes
Fabiano A
FA
Tramontina
Juliana F
JF
Kapczinski
Flávio
F
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000077152:Olanzapine; D011618:Psychotic Disorders / Q000188:drug therapy
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine